Atlas Trials

Assessing Perceptions of ML Explanations by Medical Oncologists

Clinical trial NCT06699615 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06699615
Sponsor
Abramson Cancer Center at Penn Medicine
Status
ENROLLING_BY_INVITATION
Phase
Not Applicable
Study type
INTERVENTIONAL
Oncology
Start date
2024-12-02
Primary completion
2028-04-15
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.